This one-day conference features presentations and case-based panel discussions covering the latest treatment options, clinical trials, and future directions in lung cancer
The Barbara Ann Karmanos Cancer Institute and Wayne State University will host the Second Annual Lung Cancer Symposium on Saturday, Oct. 19, 2024.
The event includes presentations from leading experts in the field of thoracic oncology, including Nasser Hanna, M.D., from Indiana University; Saiama Waqar, M.D., MSCI, from Washington University; Jay Lee, M.D., from University of California Los Angeles; Jyoti Malhotra, M.D., MPH, from City of Hope; and Antoinette Wozniak, M.D., FACP, FASCO, from the Lung Cancer Research Foundation. Thoracic oncology experts from Karmanos Cancer Institute, including Hirva Mamdani, M.D.; Dipesh Uprety, M.D., FACP; Tarik Hadid, M.D., MPH, MS, FACP; Khaled Alshabani, M.D.; and Morhaf Al Achkar, M.D., Ph.D., MS, FAAFP, will also be sharing their insights at this event.
The presentations will encompass a wide range of topics including oncologists’ and thoracic surgeons’ perspectives on the management of resectable non-small cell lung cancer (NSCLC), treatment of NSCLC harboring actionable genomic drivers and those without such genomic alterations, novel treatment options for small-cell lung cancer, and survivorship in lung cancer. The presentations will be followed by case-based panel discussions to put the plethora of emerging data into clinical perspective.
"We are very excited for this year’s symposium. This event is a vital endeavor, as the field of thoracic oncology is evolving at an unprecedented speed, marked by a surge in FDA-approved treatment options and an ever-growing number of clinical trials,” said Dr. Mamdani, medical oncologist, leader of the Thoracic Oncology Multidisciplinary Team (MDT), member of the Phase I Clinical Trials MDT, and member of the Molecular Therapeutics Research Program at Karmanos. “The symposium provides an invaluable platform for experts to dissect and interpret the latest data, empowering clinicians to navigate the complexities of this expanding field and to make individualized treatment decisions for patients with lung cancer.”
Dr. Mamdani serves as the program director of the annual Lung Cancer Symposium, a meeting of the minds she revived in 2023. She is also an associate professor in the Department of Oncology at Wayne State University (WSU) School of Medicine.
This year’s symposium will be held at Detroit Marriott Troy. Attendees may claim a maximum of 6 AMA PRA Category 1 Credit(s)™, depending on their extent of participation during the event.
Registration is required. The cost is $75 for physicians; $30 for retired physicians, pharmacists, mid-level providers, nurses, CTO staff and allied health providers; and $20 for fellows, residents and medical students. The deadline to register is Thursday, Oct. 17. Register online at karmanos.org/lung-cancer-symposium. For additional information, contact Pamelia Sydorchuk, symposium coordinator, at [email protected] or 313-576-8746.
Join the discussion during the symposium on X, LinkedIn and Facebook by using #KarmanosLung.